Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02341014
Recruitment Status : Active, not recruiting
First Posted : January 19, 2015
Last Update Posted : February 6, 2019
Sponsor:
Collaborator:
University of Nebraska
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 2020
Estimated Study Completion Date : January 2020